Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (141-150 of 320) with videos related to

Pageof 32
Sort By:
Atherosclerosis|November 26, 2013
Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohortDavid Rosenbaum, Philippe Giral, John Chapman, et al.
European Journal of Preventive Cardiology|December 22, 2012
Guidelines on CVD prevention: confusing or complementary?Guy De Backer, Alberico L Catapano, John Chapman, et al.
Proteomics. Clinical Applications|July 23, 2015
Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumabJanet S Lee, M John Chapman, Paolo Piraino, et al.
Atherosclerosis|September 3, 2002
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular riskSophie Gonbert, Sophie Malinsky, Andrei C Sposito, et al.
Transfusion|September 13, 2006
Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agentsVasudevacharya Jayarama, Jennifer Marcello, Asa Ohagen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol effluxMaryse Guerin, Wilfried Le Goff, Eric Frisdal, et al.
European Heart Journal|September 1, 2018
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicineUlrich Laufs, Ricardo Dent, Paul J Kostenuik, et al.
Journal of Lipid Research|August 18, 2010
Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemiaZélie Julia, Emilie Duchene, Natalie Fournier, et al.
Development and Psychopathology|October 21, 2016
Evaluating a social problem solving intervention for juvenile detainees: Depressive outcomes and moderators of effectivenessGerald J Haeffel, Sascha Hein, Amanda Square, et al.
Journal of Lipid Research|December 7, 2007
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjectsGiovanna Catalano, Emilie Duchene, Zélie Julia, et al.
Pageof 32

Showing results (141-150 of 320) with videos related to

Sort By:
Pageof 32
Atherosclerosis|November 26, 2013
Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohortDavid Rosenbaum, Philippe Giral, John Chapman, et al.
European Journal of Preventive Cardiology|December 22, 2012
Guidelines on CVD prevention: confusing or complementary?Guy De Backer, Alberico L Catapano, John Chapman, et al.
Proteomics. Clinical Applications|July 23, 2015
Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumabJanet S Lee, M John Chapman, Paolo Piraino, et al.
Atherosclerosis|September 3, 2002
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular riskSophie Gonbert, Sophie Malinsky, Andrei C Sposito, et al.
Transfusion|September 13, 2006
Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agentsVasudevacharya Jayarama, Jennifer Marcello, Asa Ohagen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol effluxMaryse Guerin, Wilfried Le Goff, Eric Frisdal, et al.
European Heart Journal|September 1, 2018
Why is hypercholesterolaemia so prevalent? A view from evolutionary medicineUlrich Laufs, Ricardo Dent, Paul J Kostenuik, et al.
Journal of Lipid Research|August 18, 2010
Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemiaZélie Julia, Emilie Duchene, Natalie Fournier, et al.
Development and Psychopathology|October 21, 2016
Evaluating a social problem solving intervention for juvenile detainees: Depressive outcomes and moderators of effectivenessGerald J Haeffel, Sascha Hein, Amanda Square, et al.
Journal of Lipid Research|December 7, 2007
Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjectsGiovanna Catalano, Emilie Duchene, Zélie Julia, et al.
Pageof 32